Resources
183 Results (showing 1 - 10)
Results sorted by posted date (newest first)
Results sorted by posted date (newest first)
Posted 5/5/2024 (updated 5/7/2024)
The four-module implementation toolkit developed by the National Center on Substance Abuse and Child Welfare offers strategies to develop peer support specialist programs for parents affected by substance use—whose children and families are involved with child welfare.
Posted 5/5/2024 (updated 5/7/2024)
The MaineHealth Substance Use Training team has created a toolkit for extended-release injectable buprenorphine (Sublocade).
Posted 4/19/2024
Researchers assessed whether there was a connection between buprenorphine dose and time to treatment discontinuation when fentanyl is prevalent. The results showed that a 24mg dose of buprenorphine remained in treatment longer than those prescribed 16mg. Therefore, higher buprenorphine doses could be considered to help improve treatment retention.
Posted 4/19/2024
Researchers assessed disparities in the availability of hospital-based transitional opioid programs for substance use disorder (SUD) in urban and rural settings.
Posted 4/16/2024 (updated 4/24/2024)
Adverse childhood experiences (ACEs) are events of abuse, neglect, and household dysfunction that occur between birth and 17 years of age. Multiple studies established the association between ACEs, risky behaviors, and poor physical and mental health outcomes in childhood and beyond. Rural and minority children often have higher rates of ACEs exposure than their peers.
Posted 4/12/2024
This peer reviewed journal article OUD treatment and pregnancy outcomes among pregnant patients receiving OUD care through a telehealth addiction treatment program in the US. The patients identified in the study received buprenorphine or buprenorphine and naloxone treatment.
Posted 4/5/2024
This study assessed the associations between insurance status and 6-month retention of patients with opioid use disorder on telehealth platforms. Patients whose insurance paid for their care were most likely to still be receiving buprenorphine 6 months after starting treatment. Uninsured patients who paid cash were more likely to be in treatment at 6 months than people with insurance that did not cover their care. Findings showed an association between in-network insurance benefits and retention, which may affect the opioid crisis.
Posted 3/29/2024
A planning committee of the National Academies of Sciences, Engineering, and Medicine organized and conducted a two-day virtual public workshop that brought together data experts, program implementers and evaluators, and other key interested parties to explore data collection efforts, evidence gaps, and research needs on harm reduction for people who use drugs (PWUD).
Posted 3/11/2024 (updated 3/28/2024)
This is a resource for harm reduction programs and communities looking to establish new community advisory boards (CABs) or improve upon existing ones. Syringe Services Program Community Advisory Boards: A Framework offers structured recommendations to develop, convene, and sustain effective syringe service program CABs.
Posted 3/10/2024 (updated 3/28/2024)
The Substance Abuse and Mental Health Services Administration's (SAMHSA) updated Overdose Prevention and Response Toolkit provides guidance to a wide range of individuals on preventing and responding to an overdose. It emphasizes harm reduction and access to treatment as essential aspects of overdose prevention.